Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kristen R Trexler"'
Autor:
Rayetta G. Henderson, Timothy W. Lefever, Melissa M. Heintz, Kristen R. Trexler, Susan J. Borghoff, Marcel O. Bonn-Miller
Publikováno v:
Food and Chemical Toxicology. 176:113778
Autor:
Rayetta G. Henderson, Brian T. Welsh, John M. Rogers, Susan J. Borghoff, Kristen R. Trexler, Marcel O. Bonn-Miller, Timothy W. Lefever
Publikováno v:
Food and Chemical Toxicology. 176:113786
Autor:
Joshua D Gross, Kristen R Trexler, Vincent Setola, William C. Wetsel, Shane W Kaski, Allison N White, Kim Wix, Steven G. Kinsey, David P. Siderovski
Publikováno v:
J Psychopharmacol
Background:Regulator of G protein Signaling (RGS) proteins inhibit G protein-coupled receptor (GPCR) signaling, including the signals that arise from neurotransmitter release. We have shown that RGS12 loss diminishes locomotor responses of C57BL/6J m
Autor:
Aubrie A Harland, Steven G. Kinsey, Kim Wix, Shane W Kaski, Allison N White, Kristen R Trexler, Vincent Setola, Jeffrey Aubé, Terry P. Kenakin, David P. Siderovski, Joshua D Gross, Thomas E. Prisinzano
Publikováno v:
J Pharmacol Exp Ther
Mu opioid receptor (MOR)-targeting analgesics are efficacious pain treatments, but notorious for their abuse potential. In preclinical animal models, coadministration of traditional kappa opioid receptor (KOR)-targeting agonists with MOR-targeting an
Publikováno v:
Pharmacology Biochemistry and Behavior. 177:27-33
Recently, multiple compounds have been synthesized that target the allosteric binding site(s) of CB(1). These CB(1) positive allosteric modulators, may capture the benefits of cannabinoid receptor activation without unwanted psychoactive effects, suc
Publikováno v:
Pharmacol Biochem Behav
Withdrawal from Δ9-tetrahyrocannibidol (THC) is associated with a host of dysphoric symptoms that increase probability of relapse. To date, many animal models of THC withdrawal rely on withdrawal-induced somatic withdrawal signs leaving withdrawal-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0aa2e378742cac3bba618e19470ae4
https://europepmc.org/articles/PMC7415667/
https://europepmc.org/articles/PMC7415667/
Publikováno v:
Drug and alcohol dependence
Background Recent years have seen a rise in the diversity and use of synthetic cannabinoids. The present study evaluated the behavioral effects of the third-generation indazole-3-carboxamide-type synthetic cannabinoid, AB-FUBINACA. Methods Adult male
Autor:
Margaret S. Jones, Kristen R Trexler, Steven G. Kinsey, Joshua D Gross, Austin W. McKitrick, Molly S. Crowe, David P. Siderovski, Sara R. Nass
Background A subset of cannabis users develop some degree of Cannabis Use Disorder (CUD). Although behavioral therapy has some success in treating CUD, many users relapse, often citing altered sleep, mood, and irritability. Preclinical animal tests o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3698d7e4ac44f8100bd002ded70e593e
https://europepmc.org/articles/PMC6404969/
https://europepmc.org/articles/PMC6404969/